Overview

Effects of Oral Salmon Calcitonin in Human Osteoarthritis

Status:
Terminated
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
To assess the safety, tolerability and clinical efficacy of oral salmon calcitonin in patients suffering from osteoarthritis
Phase:
Phase 2
Details
Lead Sponsor:
Université Catholique de Louvain
Collaborator:
Novartis
Treatments:
Calcitonin
Calcitonin Gene-Related Peptide
Katacalcin
Salmon calcitonin